Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
11/22/2000 | EP1053321A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
11/22/2000 | EP1053320A2 Human transport-associated molecules |
11/22/2000 | EP1053319A2 Human genes and gene expression products ii |
11/22/2000 | EP1053318A2 Cdnas encoding secreted proteins |
11/22/2000 | EP1053311A2 Compositions and methods for using a lysing matrix for isolating dna |
11/22/2000 | EP1053308A1 Dendritic enriched secreted lymphocyte activation molecule |
11/22/2000 | EP1053253A1 Novel gaba b? receptor dna sequences |
11/22/2000 | EP1053245A1 45 human secreted proteins |
11/22/2000 | EP1052909A1 Flavouring materials from yeast extracts |
11/22/2000 | EP0550696B1 Purified thermostable nucleic acid polymerase enzyme from thermosipho africanus |
11/22/2000 | CN1274387A HCVE mimotopes of hypervariable region 1 and uses |
11/22/2000 | CN1274386A Genetic control of plant growth and develepmnt |
11/22/2000 | CN1274260A Hypersensitive response elicitor from i(Erwinia Amylovora) and its use |
11/22/2000 | CN1274259A Hypersensitive response elicitor from i(pseudomonas syringae) and its use |
11/22/2000 | CN1274009A Method of soaking maize and soaked water containing low reduced sugar therefrom |
11/22/2000 | CN1274006A Method for artificially cultivating cordyceps |
11/22/2000 | CN1273839A Transfer and modification of intestinalprobiotics fermentation culture medium to natural medicine |
11/22/2000 | CN1273838A Nutritive composition containing symbiotic fermentation culture medium of dead probiotics |
11/22/2000 | CN1058753C Process for producing polysacharides |
11/22/2000 | CN1058749C Active biological protein source compsns. and its preparing method and use |
11/21/2000 | US6150588 DNA encoding antimicrobial proteins from impatiens |
11/21/2000 | US6150502 Polypeptides expressed in skin cells |
11/21/2000 | US6150472 Block copolymers crosslinked to polysaccharide with cellulose derivatiiives, polyacrylic acid, polyethers and polyethylenimine, |
11/21/2000 | US6150340 RNA-dependent amidotransferase from Staphylococcus aureus |
11/21/2000 | US6150176 Fluorescent protein sensors for measuring the pH of a biological sample |
11/21/2000 | US6150156 Bacillus thuringiensis isolates active against sucking insects |
11/21/2000 | US6150150 Human brain phosphodiesterase |
11/21/2000 | US6150149 Nucleotide and amino acid sequence; recombinant production; for use in breeding technology of basidiomycetes fungi and plants |
11/21/2000 | US6150140 Process for the biotransformation of colchicinoid compounds into the corresponding 3-glycosyl derivatives |
11/21/2000 | US6150139 Preparing bactericide; culturing cells, separating the supernatant, separate bateriocin from supernatant, recover bacteriocin |
11/21/2000 | US6150137 Immunosuppressant target proteins |
11/21/2000 | US6150135 Dirofilaria and brugia thioredoxin peroxidase type-2 (TPX-2) nucleic acid molecules, and uses thereof |
11/21/2000 | US6150134 Recombinant microorganism polypeptide; for the diagnosis, treatment and prevention of preferential microorganismal infections; for the purification of recombinant polypeptides |
11/21/2000 | US6150133 Fermentation control |
11/21/2000 | US6150132 Vector coding polypeptides for the diagnosis and treatment of allergies and atherosclerosis; for the prevention of graft ejection and injuries to stem cell caused by anticarcinogenic agents |
11/21/2000 | US6150116 Transcription factor DP-1 antibody |
11/21/2000 | US6150093 Unique associated Kaposi's sarcoma virus sequences and uses thereof |
11/21/2000 | US6150081 Nucleated with peptizer |
11/21/2000 | US6149919 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines |
11/21/2000 | CA2166691C Bacillus thuringiensis transposon tn5401 and its use in a site-specific recombination system for bacillus thuringiensis strain development |
11/21/2000 | CA2051090C Cephalosporin c acylase |
11/21/2000 | CA1341143C Purified thermostable enzyme |
11/16/2000 | WO2000068426A1 Ups |
11/16/2000 | WO2000068411A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
11/16/2000 | WO2000068407A1 Clostridium strains which produce ethanol from substrate-containing gases |
11/16/2000 | WO2000068401A1 Recombinant penicillium funiculosum for homologous and heterologous protein production |
11/16/2000 | WO2000068400A1 Method for producing a recombinant protein |
11/16/2000 | WO2000068396A2 Bacillus circulans xylanase mutants |
11/16/2000 | WO2000068394A1 Epoxide hydrolases of aspergillus origin |
11/16/2000 | WO2000068387A2 Nucleic acids and proteins with interferon-beta activity |
11/16/2000 | WO2000068386A1 Autotaxin variants and uses to treat diseases of metabolism |
11/16/2000 | WO2000068385A2 Novel nucleic acids and proteins with growth hormone activity |
11/16/2000 | WO2000068384A2 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS |
11/16/2000 | WO2000068383A2 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
11/16/2000 | WO2000068382A1 PrP-LIKE GENE |
11/16/2000 | WO2000068381A1 Cytokine receptor mouse zcytor10 |
11/16/2000 | WO2000068380A2 Extracellular matrix and adhesion-associated proteins |
11/16/2000 | WO2000068376A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
11/16/2000 | WO2000068375A2 Modified pm and pu promoters of tol plasmids |
11/16/2000 | WO2000068374A1 Regulation of viral gene expression |
11/16/2000 | WO2000068372A1 Combinatorial metabolic libraries |
11/16/2000 | WO2000068360A1 A histidine kinase, 636 hk, of staphylococcus aureus |
11/16/2000 | WO2000068268A1 Human gabab receptor 1 promoters |
11/16/2000 | WO2000068261A2 Attenuated microorganisms for the treatment of infection |
11/16/2000 | WO2000068258A2 Compounds exhibiting an antibiotic activity |
11/16/2000 | WO2000068253A1 Dna promoter sequence for gene expression |
11/16/2000 | WO2000068247A2 Serine proteases |
11/16/2000 | WO2000068243A1 Methods using mechanisms of action of aroa |
11/16/2000 | WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response |
11/16/2000 | WO2000067700A2 Recombinant vaccine against botulinum neurotoxin |
11/16/2000 | WO2000067696A2 Lactic acid bacteria with anxiolytic properties and uses thereof |
11/16/2000 | WO2000053633A3 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases |
11/16/2000 | WO2000042204A3 Trans-acting factors in yeast |
11/16/2000 | WO2000042191A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
11/16/2000 | WO2000042179A3 Complex-forming proteins |
11/16/2000 | WO2000042168A3 Bifidobacterium in the treatment of inflammatory disease |
11/16/2000 | WO2000039285A3 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof |
11/16/2000 | WO2000039281A3 Liquid starter cultures having improved storage stability and use thereof |
11/16/2000 | WO2000037639A3 Lymphocytic membrane proteins |
11/16/2000 | WO2000037613A3 Human akt-3 |
11/16/2000 | WO2000036118A3 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
11/16/2000 | WO2000034511A3 Aβ-PEPTIDE SCREENING ASSAY |
11/16/2000 | WO2000029603A3 Low cost manufacture of oligosaccharides |
11/16/2000 | WO2000026370A3 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
11/16/2000 | WO2000026241A3 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
11/16/2000 | WO2000024907A3 Library of novel "unnatural" natural products |
11/16/2000 | WO2000023621A3 Visualization of rna in living cells |
11/16/2000 | WO2000023466A3 Human rna binding proteins |
11/16/2000 | WO2000020448A3 Nlk1 -interacting proteins |
11/16/2000 | WO2000018916A3 Human genes and gene expression products |
11/16/2000 | WO2000009549A3 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
11/16/2000 | WO2000006717A9 Improved transformation efficiency in phage display through modification of a coat protein |
11/16/2000 | WO2000005375A9 Gbs toxin receptor |
11/16/2000 | WO2000000648A9 Product and method for pre-emptive potential in remediation of oil spills |
11/16/2000 | DE19949579C1 Microorganism with deregulated cysteine metabolism, useful for high-level production of cysteine and its derivatives, has increased activity of the CysB transcription regulator |
11/16/2000 | DE19921710A1 Biomelanin Biomelanin |
11/16/2000 | DE19921561A1 Symbiotic microorganisms with a combination of specified yeasts and bacteria which ferment sugar into alcohol and simultaneously oxidize the alcohol into organic acids |
11/16/2000 | CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response |
11/16/2000 | CA2373759A1 Serine proteases |
11/16/2000 | CA2373507A1 Prp-like gene |